Holen Sie sich die Stockscreener-App
1.62
2.53%
0.04
Handel nachbörslich:
1.63
0.010
+0.62%
Schlusskurs vom Vortag:
$1.58
Offen:
$1.59
24-Stunden-Volumen:
367.70K
Relative Volume:
1.27
Marktkapitalisierung:
$48.71M
Einnahmen:
$210.70K
Nettoeinkommen (Verlust:
$-21.37M
KGV:
-1.4727
EPS:
-1.1
Netto-Cashflow:
$-21.10M
1W Leistung:
-4.71%
1M Leistung:
-8.47%
6M Leistung:
-23.94%
1J Leistung:
+39.66%
1-Tages-Spanne:
$1.56
$1.90
1-Wochen-Bereich:
$1.5251
$1.90
52-Wochen-Spanne:
$0.89
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Vergleichen Sie GANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.62 | 58.56M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
Gain Therapeutics Inc. Stock Analysis and ForecastHigh-octane investment gains - jammulinksnews.com
What analysts say about Gain Therapeutics Inc. stockMarket-leading growth rates - printweek.in
What drives Gain Therapeutics Inc. stock priceRemarkably fast returns - jammulinksnews.com
What drives Monte Rosa Therapeutics Inc. stock priceExplosive portfolio gains - Autocar Professional
Aardvark Therapeutics Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
What drives Allogene Therapeutics Inc. stock priceTremendous gains - jammulinksnews.com
Is Nurix Therapeutics Inc. a good long term investmentSkyrocketing investment returns - Jammu Links News
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Abbott Laboratories (ABT) and ANI Pharmaceuticals (ANIP) - The Globe and Mail
Is Grace Therapeutics Inc. a good long term investmentTremendous gains - jammulinksnews.com
Healthcare Stocks to Watch: Gain Therapeutics, Abbott Laboratories, and ANI Pharmaceuticals - AInvest
Is vTv Therapeutics Inc. a good long term investmentTremendous gains - Jammu Links News
Bicara Therapeutics Inc. Stock Analysis and ForecastHigh-velocity gains - jammulinksnews.com
What drives Mineralys Therapeutics Inc. stock priceHigh-octane gains - Jammu Links News
Is Soleno Therapeutics Inc. a good long term investmentSuperior trading gains - Jammu Links News
What drives Avalo Therapeutics Inc. stock priceExceptional risk-adjusted gains - Jammu Links News
What analysts say about Gain Therapeutics Inc. stock outlookLow Risk High Reward Picks - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
Is Heron Therapeutics Inc. stock a good hedge against inflationDaily Gain Forecast - Newser
What risks could impact LOGC stock performanceFree Expert-Led Investment Training - Newser
Gain Therapeutics Announces $7 Million Public Offering - TipRanks
Form 424B5 Gain Therapeutics, Inc. - StreetInsider
How Nurix Therapeutics Inc. stock performs during market volatility200 Percent Gain Alert - Newser
Why Gain Therapeutics Inc. stock attracts strong analyst attentionDaily Stock Radar - beatles.ru
Neurodegenerative Biotech's Capital Crunch: The Dilution Dilemma in $7M Offerings - AInvest
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering - The Manila Times
Gain Therapeutics on pricing stock-and-warrants offering - TradingView
Gain Therapeutics Secures $7M Funding to Advance Novel Parkinson's Treatment Pipeline - Stock Titan
US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus - Benzinga
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket - inkl
Gain Therapeutics' High-Stakes Gamble: Can GT-02287 Rewrite the Neurodegenerative Treatment Playbook? - AInvest
Gain Therapeutics Plans Public Offering of Common Shares, Warrants - MarketScreener
Gain Therapeutics falls on equity offering plans - TradingView
Gain Therapeutics Announces Proposed Public Offering - The Manila Times
Gain Therapeutics stock falls after announcing public offering By Investing.com - Investing.com Canada
Gain Therapeutics stock falls after announcing public offering - Investing.com
Gain Therapeutics, Inc. Proposes Underwritten Public Offering of Common Stock and Warrants - Quiver Quantitative
Gain Therapeutics Unveils Strategic Public Offering: Funding Next-Gen Parkinson's Treatment Development - Stock Titan
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser
How Maze Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser
What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser
What makes Gain Therapeutics Inc. stock price move sharplyReturn Optimized Trade Insights - Newser
What makes Akero Therapeutics Inc. stock price move sharplyFree Access to Community - Newser
Why Sangamo Therapeutics Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):